OVER THE COUNTER DRUGS MARKET ANALYSIS
Global Over the Counter Drugs Market: Key Developments
In January 2020, Sanofi acquired Synthorx Inc. It is a clinical-stage biotechnology company focused upon improving the lives of people with cancer and autoimmune disorders.
In September 2019, L'Oreal launched its new over-the-counter product AcneFree (Adapalene Gel) a topical retinoid treatment for acne-prone skin.
In August 2019, Bayer and BlueRock Therapeutics signed an agreement under which Bayer will fully acquire BlueRock, a biotechnology company focused on developing engineered cell therapies in the fields of neurology, cardiology, and immunology, using a proprietary induced pluripotent stem cell (iPSC) platform.
In July 2019, Sanofi and Roche signed an agreement for the exclusive over-the-counter (OTC) rights to Tamiflu to prevent and treat influenza or flu in the United States.
In April 2019, Johnson & Johnson acquired Auris Health Inc., which advances its commitment to combating lung cancer and expands its digital surgery portfolio across surgical specialties.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India :